Tasmar
Generic name: Tolcapone
Drug class:
Dopaminergic antiparkinsonism agents
Usage of Tasmar
Tasmar is used together with other medicines (Carbidopa and Levodopa) to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. This medicine increases levels of levodopa in the body.
Tasmar is usually given to people who are already taking Carbidopa and levodopa but have not had successful treatment of symptoms.
Tasmar may also be used for purposes not listed in this medication guide.
Tasmar side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, Tasmar can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, or dark colored urine.
Also call your doctor at once if you have:
Certain side effects may be more likely in older adults.
You may have increased sexual urges, unusual urges to gamble, or other intense urges while taking Tasmar. Talk with your doctor if this occurs.
Common side effects of Tasmar may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Tasmar
You should not use Tasmar if you are allergic to it, or if you have:
Do not use Tasmar if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, Selegiline, tranylcypromine, and others.
Tasmar can cause liver failure. You may be required to read and sign a Patient Consent form before you get a prescription for this medicine.
To make sure Tasmar is safe for you, tell your doctor if you have ever had:
People with Parkinson's disease may have a higher risk of skin cancer (melanoma). Talk to your doctor about this risk and what skin symptoms to watch for.
It is not known whether Tasmar will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It is not known whether tolcapone passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.
Relate drugs
- Apokyn
- Apomorphine
- Apomorphine (Subcutaneous)
- Apomorphine (Sublingual)
- Azilect
- Comtan
- Carbidopa
- Carbidopa and levodopa
- Carbidopa and levodopa (Oral)
- Carbidopa and levodopa enteral
- Carbidopa, entacapone, and levodopa
- Dhivy
- Duopa
- Entacapone
- Gocovri
- Inbrija
- Kynmobi
- Levodopa
- Levodopa (Oral)
- Lodosyn
- Mirapex
- Mirapex ER
- Neupro
- Ongentys
- Opicapone
- Osmolex ER
- Parcopa
- Pramipexole
- Rasagiline
- Requip
- Requip XL
- Ropinirole
- Rotigotine
- Rotigotine transdermal
- Rytary
- Safinamide
- Sinemet
- Sinemet 10-100
- Sinemet 25-100
- Sinemet 25-250
- Sinemet CR
- Stalevo 100
- Stalevo 125
- Stalevo 150
- Stalevo 200
- Stalevo 50
- Stalevo 75
- Tasmar
- Tolcapone
- Xadago
How to use Tasmar
Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using Tasmar.
Follow all directions on your prescription label. Your doctor may occasionally change your dose. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Do not take Tasmar as your only Parkinson's medication. This medicine must be used in combination with carbidopa and levodopa.
Tasmar is usually taken three times a day. The first dose is taken with your first daily dose of carbidopa and levodopa. The second and third doses of tolcapone are taken 6 and 12 hours later.
Follow your doctor's dosing instructions very carefully.
Tasmar may be taken with or without food.
Tasmar may cause you to fall asleep during normal Daytime activities such as working, talking, eating, or driving. You may fall asleep suddenly, even after feeling alert. Tell your doctor if you have any problems with daytime sleepiness or drowsiness.
Your liver function will need to be checked often: Every 2 to 4 weeks for the first 6 months of treatment, and then as often as your doctor recommends.
Call your doctor if your symptoms do not improve after 3 weeks of treatment.
Do not stop using Tasmar suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using this medicine.
Store at room temperature in a tightly closed container, away from moisture and heat.
Warnings
You should not use this medicine if you have liver disease, if you have ever had liver problems caused by Tasmar, or if you have ever had muscle damage or fever and confusion caused by using any medication.
Do not use Tasmar if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.
Tasmar can cause liver failure. Call your doctor at once if you have unusual tiredness, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). Your liver function will need to be checked often.
What other drugs will affect Tasmar
Taking Tasmar with other drugs that make you sleepy can worsen this effect. Ask your doctor before taking a sleeping pill, opioid pain medication, muscle relaxer, or medicine for anxiety, depression, or seizures.
Other drugs may interact with tolcapone, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions